Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | WRN | Q14191 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.33 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14472846 | 0.90 | NAAA (0.43) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL22624814 | 0.89 | NAAA (0.36) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL27853451 | 0.84 | NAAA (0.39) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL26703700 | 0.82 | SERPINE1 (0.32) | GAAMGAMSIMGAM2SERPINE1 | |
| SCHEMBL12956462 | 0.82 | NAAA (0.38) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL30175577 | 0.82 | NAAA (0.38) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL6785073 | 0.82 | SERPINE1 (0.32) | GAAMGAMSIMGAM2SERPINE1 | |
| SCHEMBL12628468 | 0.82 | LMNA (0.44) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL13771559 | 0.81 | LMNA (0.42) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL31110547 | 0.80 | MGAM (0.44) | ALDH1A1GAAMGAMSIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115175735-B | Antiviral compounds | 吉利德科学公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-118165034-A | Nucleotide compound, composition and application thereof | 深圳市塔吉瑞生物医药有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-104856679-A | Breath analysis systems and methods for asthma, tuberculosis and lung cancer diagnostics and disease management | TRICORN TECH CORP | 2015-08-26 | — | — | CN | disclosed |
| WO-2014118251-A1 | UV-CURABLE COATING COMPOSITION | BAYER MATERIALSCIENCE AG (DE) | 2014-08-07 | — | — | WO | disclosed |
| CN-102656180-A | Lupeol-type triterpene derivatives as antivirals | HETERO RESEARCH FOUNDATION | 2012-09-05 | — | — | CN | disclosed |
| CN-102300502-A | Breath analysis system and method for asthma, tuberculosis and lung cancer diagnosis and disease management | — | 2011-12-28 | — | — | CN | disclosed |
| US-20040248981-A1 | Benzamidine derivatives | SANKYO COMPANY, LIMITED (JP) | 2004-12-09 | — | — | US | disclosed |
| US-20040010009-A1 | Benzamidine derivatives | SANKYO COMPANY, LIMITED (JP) | 2004-01-15 | — | — | US | disclosed |
| US-6555556-B1 | N-(4-(1-acetimidoylpiperidin-4-yl)oxyphenyl)-N-((E)-3-(3 -amidinophenyl)-2-methyl-2-propenyl)sulfamoylacetic acid dihydrochloride for example; factor Xa inhibitors | SANKYO COMPANY, LIMITED (JP) | 2003-04-29 | — | — | US | disclosed |
| EP-1245564-A1 | BENZAMIDINE DERIVATIVES | Sankyo Company, Limited (JP) | 2002-10-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040010009-A1 | Benzamidine derivatives | HABP2, F7, F2 | NAAA 145/4885ALDH1A1 1918/4885CYP1A2 854/4885 |
| US-20040248981-A1 | Benzamidine derivatives | HABP2, F7, F2 | NAAA 140/4885ALDH1A1 1987/4885CYP1A2 835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.